Literature DB >> 8778193

HCV-associated hepatocellular carcinoma without cirrhosis.

A el-Refaie1, K Savage, S Bhattacharya, S Khakoo, T J Harrison, M el-Batanony, S Nasr, N Mokhtar, K Amer, P J Scheuer, A P Dhillon.   

Abstract

BACKGROUND/AIMS: Hepatocellular carcinoma is an aggressive malignancy and carries a poor prognosis. Hepatitis B and C virus infection, cirrhosis and aflatoxin B1 exposure are considered major risk factors. The role of hepatitis C virus in the causation of hepatocellular carcinoma has been debated. It is a positive, single-stranded RNA virus without a DNA intermediate in its replicative cycle, so that integration of hepatitis C virus nucleic acid sequences into the host genome seems unlikely. The most plausible explanation of hepatitis C virus-associated hepatocellular carcinoma so far is that the virus causes necroinflammatory hepatic disease with vigorous regeneration, fibrosis, and eventually cirrhosis. The aim of this study was to examine the relationship of hepatitis C, cirrhosis and hepatocellular carcinoma.
METHODS: Sixty-six consecutive patients with hepatocellular carcinoma undergoing resection or transplantation at the Royal Free Hospital were reviewed. A combination of serological data and polymerase chain reaction assay was used to assign hepatitis C virus and hepatitis B virus infection.
RESULTS: We found four HCV-RNA positive patients with hepatocellular carcinoma without cirrhosis. All four cases were positive for HCV-RNA and negative for all markers of hepatitis B virus infection.
CONCLUSIONS: These four cases show that hepatocellular carcinoma may develop in patients with hepatitis C virus without pre-existing cirrhosis. However, the precise role of hepatitis C virus in hepatocarcinogenesis, the carcinogenic potential of the different genotypes and whether this role is influenced by other risk factors still have to be clarified.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8778193     DOI: 10.1016/s0168-8278(96)80005-5

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  12 in total

1.  Development of hepatocellular carcinoma in a patient with Crohn's disease treated with azathioprine.

Authors:  Jason Samarasena; Mark Borgaonkar
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

Review 2.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis.

Authors:  Asmaa-Ibrahim Gomaa; Shahid-A Khan; Mireille-B Toledano; Imam Waked; Simon-D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

Review 3.  [1997 gastroenterology update--II].

Authors:  W Fischbach; V Gross; J Schölmerich; C Ell; P Layer; W E Fleig
Journal:  Med Klin (Munich)       Date:  1998-03-15

4.  Outcomes Following Resection of Hepatocellular Carcinoma in the Absence of Cirrhosis.

Authors:  Richard H Lewis; Evan S Glazer; David M Bittenbinder; Thomas O'Brien; Jeremiah L Deneve; David Shibata; Stephen W Behrman; Jason M Vanatta; Sanjaya K Satapathy; Paxton V Dickson
Journal:  J Gastrointest Cancer       Date:  2019-12

5.  Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis.

Authors:  S Kubo; A Tamori; K Ohba; T Shuto; T Yamamoto; H Tanaka; S Nishiguchi; K Wakasa; K Hirohashi; H Kinoshita
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

6.  Occurrence of HCC in asymptomatic HCV-related chronic hepatitis.

Authors:  Marcello Persico; Bruno Palmentieri; Leonardo Coppola; Giovanni Di Giacomo Russo; Fedele De Marino; Ilario De Sio; Roberto Torella
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

Review 7.  Experimental mouse models for hepatocellular carcinoma research.

Authors:  Femke Heindryckx; Isabelle Colle; Hans Van Vlierberghe
Journal:  Int J Exp Pathol       Date:  2009-08       Impact factor: 1.925

8.  Cancer-associated carbohydrate antigens as potential biomarkers for hepatocellular carcinoma.

Authors:  Chen-Shiou Wu; Chia-Jui Yen; Ruey-Hwang Chou; Shiou-Ting Li; Wei-Chien Huang; Chien-Tai Ren; Chung-Yi Wu; Yung-Luen Yu
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

9.  Nondegradable Collagen Increases Liver Fibrosis but Not Hepatocellular Carcinoma in Mice.

Authors:  Jacopo Baglieri; Cuili Zhang; Shuang Liang; Xiao Liu; Takahiro Nishio; Sara B Rosenthal; Debanjan Dhar; Hua Su; Min Cong; Jidong Jia; Mojgan Hosseini; Michael Karin; Tatiana Kisseleva; David A Brenner
Journal:  Am J Pathol       Date:  2021-06-11       Impact factor: 5.770

10.  Long-term survival after resection of hepatocellular carcinoma.

Authors:  Ki Hoon Kim; Young-Kil Choi
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2012-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.